Published on 21 Dec 2023 on GuruFocus.com via Yahoo Finance
Insider Sell: Vaxcyte Inc CFO Andrew Guggenhime Disposes of 8,000 Shares
Vaxcyte Inc (NASDAQ:PCVX), a company specializing in vaccine innovation with a focus on improving global health through the development of superior vaccines, has reported an insider selling event. According to a recent SEC filing, the insider, Andrew Guggenhime, who serves as the President and CFO, sold 8,000 shares of the company on December 18, 2023.
Warning! GuruFocus has detected 3 Warning Sign with PCVX.
The transaction was executed at an average price of $60.18 per share, which resulted in a total value of $481,440. Following this transaction, the insider's direct ownership in Vaxcyte Inc has been adjusted accordingly.